|
Ojha RP, Thertulien R, Fischbach LA. Racial under-representation in clinical trials: Consequence, myth, and proposition. Epidemiol Focus 2008;1(1):4-6.
Rohit P Ojha, Raymond Thertulien, Yi Zhou, and Lori A Fischbach. Prostate cancer treatment and risk of acute myeloid leukemia in a population-based
prospective cohort. J Clin Oncol 26: 2008 (May 20 suppl; abstr 5073).
Barlogie B, Tricot G, Haessler J, van Rhee F, Cottler-Fox M, Anaissie E, Waldron J, Pineda-Roman M,
Thertulien R, Zangari M, Hollmig K, Mohiuddin A, Alsayed Y, Hoering A, Crowley J and Sawyer J.
Cytogenetically defined myelodysplasia after melphalan based autotransplants for multiple myeloma
linked to poor hematopoietic stem cell mobilization: the Arkansas experience in more than 3000
patients treated since 1989. Blood. 2008 Jan 1;111(1):94-100. Epub 2007 Sep 25.
R.P. Ojha, Y. Zhou, L.A. Fischbach, M.M. Phillips and R. Thertulien. An Ecologic Perspective
of Multiple Myeloma Incidence: Heterogeneous Effects of Industrial Exposures and Socioeconomic
Status. Annals of Epidemiology 2007; 17(9):730.
Rohit P Ojha, Thertulien R, Deepak Prabhakar, Yi Zhou, and Lori A Fischbach. A Comparative
Investigation of Therapeutic Approaches for Primary Prostate Cancer and Risk of Acute Myeloid Leukemia.
Blood (ASH Annual Meeting Abstracts), Nov 2007; 110: 1816.
|
